[CUE] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
11-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 5.85%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 1,245 14,941 3,154 3,458 1,143 0 0 -
PBT -53,010 -43,666 -44,579 -36,286 -38,155 -23,234 -7,658 38.03%
Tax -214 495 206 412 825 0 0 -
NP -52,796 -44,161 -44,785 -36,698 -38,980 -23,234 -7,658 37.93%
Tax Rate - - - - - - - -
Total Cost 54,041 59,103 47,939 40,156 40,123 23,234 7,658 38.47%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -4,239.87 -295.56 -1,419.79 -1,061.25 -3,411.53 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.48 -1.41 -1.56 -1.66 -1.94 -1.13 -0.37 25.97%
EPS Diluted -1.48 -1.41 -1.56 -1.66 -1.94 -1.13 -0.37 25.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.